F. NO. 8 (6)/2004/DP/NPPA-Div.II
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY
NEW DELHI, DATED THE 4/1/2005
ORDER
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;
TABLE
| Sl. No. | Name of the Formulation | Pack Size | Existing Retail Price (Rs.) | Retail Price without Excise Duty | Excise Duty (Rs.) | Revised Retail Price with Excise Duty (Rs.) |
|---|---|---|---|---|---|---|
| 1 | Monocomponent Insulin Huminsulin NPH U 100 Cartridge (Human Insulin) Batch No. FF4J31J – 2500 CartridgeBatch No. FF4L65B – 2500 Cartridge Batch No. FF4S18E – 2500 Cartridge |
3.0ml Cartridge |
— — |
208.94 208.94 |
0.00 0.00 |
208.94 208.94 |
| 2 | Monocomponent Insulin Huminsulin Regular U100 Cartridge (Human Insulin) Batch No. FF4H21C -4,000 CartridgeBatch No. FF4L62C -3,265 Cartridge Batch No. FF4M85F -1,460 Cartridge and Batch No. FF4X75C – 2540 Cartridge |
3.0ml Cartridge |
— — |
208.94 208.94 |
0.00 0.00 |
208.94 208.94 |
| 3 | Monocomponent Insulin Huminsulin 30/70 U 100 Cartridge (Human Insulin) Batch No. FF4L32E- 74,860 CartridgeBatch No. FF4L69G- 25,000 Cartridge Batch No. FF4V84B- 70,000 Cartridge |
3.0ml Cartridge |
— — |
208.94 208.94 |
0.00 0.00 |
208.94 208.94 |
| 4 | Monocomponent Insulin Humaject R (Regular) (Human Insulin) Each ml of Humanject R (Regular)- Insulin contains 100 IUHuman Insulin Ph. Eur. (r-DNA origin) as active ingredient (B.No. FF4M77H / Qty. 5000 Cartridges) |
3.0ml Cartridge | — | 261.18 | 0.00 | 261.18 |
| 5 | Monocomponent Insulin Humaject 30/70 U 100 cartridge (Human Insulin) Each ml of 30% Neutral Insulin Solution & 70% Isophane Suspension Human Contians: 100 IUHuman Insulin Ph. Eur. (r-DNA origin) as active ingredient (B.No. FF4N46D / Qty. 8120Cartridges) |
3.0ml Cartridge | — | 261.18 | 0.00 | 261.18 |
| 6 | Monocomponent Insulin Isophane Insulin Suspension(100IU/ml) Huminsulin N (NPH) Each ml of Isophane Insulin Human Suspension contain: 100 IU Human Insulin Ph. Eur. (r-DNA origin) (B.No. HIN016A / Qty. 30 vials) |
10ml Vial | — | 407.95 | 0.00 | 407.95 |
| 7 | Monocomponent Insulin Isophane Insulin Suspension(100IU/ml) Huminsulin R (Regular) Each ml of Isophane Insulin Human Suspension contain: 100 IU Human Insulin Ph. Eur. (r-DNA origin) (B.No. HIR017A / Qty. 30 vials) |
10ml Vial | — | 407.95 | 0.00 | 407.95 |
| 8 | Monocomponent Insulin 30% Neutral Insulin Solution & 70% Isophane Suspension (100 iu/ml) Huminsulin 30/70 Each ml of 30% Neutral Insulin Solution & 70% Isophane Suspension Human contains: 100 IU Human Insulin Ph. Eur. (r-DNA origin) (B.No. HIM059A / Qty. 30 vials) |
10ml Vial | — | 407.95 | 0.00 | 407.95 |
2. This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of
(a) the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and
(b) the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.
3.(a) The prices fixed/revised are the maximum retail prices (inclusive of excise duty and exclusive of local taxes, if any) for the specified pack and packs of similar strength, and companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order.
(b) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
4. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(A. K. PAL)
Dy. Director
PN/79/2004/F
M/s Eli-Lilly and Company (India) Pvt. Ltd.
Plot No. 92, Sector-32
Gurgaon-122001
Haryana
Last Page Updated: 06-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)